Rheumatoid Arthritis News You Can Use, 2021 - Everyday Health
At the American College of Rheumatology (ACR) Convergence, its annual congress, held online November 3–9, 2021, five panels addressed new research concerning rheumatoid arthritis (RA), a chronic inflammatory autoimmune disease of the joints. RA affects 1.3 million Americans and is 2.5 times more common in women, according to Cleveland Clinic. Symptoms include fatigue and pain and stiffness at the joint site. 5 Top Takeaways From the Rheumatology Conference for People With Rheumatoid Arthritis 1. Ultra-Low Dose Rituximab Controls Disease Activity for Most RA Patients What's new Rituximab, a monoclonal antibody, is registered for treating RA at the dose of 2x1000 milligrams (mg) per six months. In previous studies, 1x1000 mg or 2x500 mg per six months were equally effective. The new study, an extension of previous studies, found that even lower doses may be effective for many people living with RA. Research details In a previous study, doses of 200 and 500 mg of rituximab a...